進階篩選

Technical category
    • A genomic marker guided roadmap to treat hepatocellular carcinoma

      Bio-tech & New Drugs FutureTech A genomic marker guided roadmap to treat hepatocellular carcinoma

      This is a method for identifying single nucleotide polymorphisms (GALNT14 genotypes) of a target nucleic acid for predicting whether a patient suffering from HCC will respond to combination chemotherapy. Accordingly, physicians can decide whether the HCC patients should receive chemotherapyTACE. This method could also predict prognosis in multiple gastrointestinal cancers.
    • 基於轉移學習之青光眼眼底照片診斷系統-適於各醫療院所之平台發展

      AI & IOT Application FutureTech 基於轉移學習之青光眼眼底照片診斷系統-適於各醫療院所之平台發展

      A transfer learning-assisted glaucoma detection system was build first with training images from the fundus images database of Taipei Veterans General Hospital,then fine-tuned to improve its applicability on fundus images from different datasets. This system aims to assist clinic-based glaucoma screening to increase the diagnostic rate of glaucoma by using existing healthcare facility.
    • Personalized emotion sensing for spoken dialog interface

      AI & IOT Application FutureTech Personalized emotion sensing for spoken dialog interface

      The technology is an integrated solution incorporating the retrievable personality for multimodal emotion sensing for spoken services. This framework provides a real-world flexibility that enables the estimation of the target speaker emotion states without manual personalization.
    • 治療多種癌症與纖維化之首創抗體新藥

      FutureTech 治療多種癌症與纖維化之首創抗體新藥

      Ninety percent of human diseases are related to abnormal inflammation. WJM team has successfully developed a new monoclonal antibody that can inhibit a key inflammation protein. Animal experiments have accumulated more than ten disease modes, including a variety of solid tumors, fibrosis, degenerativecardiovascular diseases. This antibody is qualified as an orphan drug for the treatment of IPF. New coronary pneumonia has greatly increased the demand for pulmonary fibrosis treatment,has also become an important target for mergersacquisitions of global pharmaceutical companies.
    • Monolithic hybrid type quantum dots micro-light-emitting diodes for the full-color pixel array

      Electronic & Optoelectronics FutureTech Monolithic hybrid type quantum dots micro-light-emitting diodes for the full-color pixel array

      A wavelength tunable micro-light-emitting diodes fabricated by the nanometer-level etching technology, the strain-induced engineering can effectively shift the emission wavelength from green to blue. Meanwhile, we introduced the ALD for the passivation layer,the super inkjet printing system used to form the color-conversion layer to emissive red light. Finally, a hybrid type full-color micro-LED has been fabricated with the monolithic epitaxial wafer.
    • DBPR807: a CXCR4-Targeted Antagonist

      Precision Health Ecosystem FutureTech DBPR807: a CXCR4-Targeted Antagonist

      DBPR807 can significantly suppress tumor growth, prevent distant metastasis, reduce angiogenesis, normalize tumor microenvironment and promote cytotoxic T-cell infiltration. In various HCC models, DBPR807 itself can prolong overall survival as effectively as marketed anti-angiogenic agent sorafenib and immune checkpoint inhibitor anti-PD-1 Ab. What’s more, its combination therapy with either sorafenib or anti-PD-1 Ab can extend life expectancy even more significantly than aforementioned monotherapy.
    • SS-MRAM: A superlattice based STT-MRAM with extra-high performance

      Electronic & Optoelectronics FutureTech SS-MRAM: A superlattice based STT-MRAM with extra-high performance

      SS-MRAM is a superlattice based magnetoresistive RAM, in which the barrier is made of superlattice to replace crystal MgO (001). The superlattice is a high spin polarization artificial metamaterial, which is composed of stable insulatormetal materials. Compared with the current STT-MRAM, SS-MRAM has the advantages of low readingwriting power consumption, fast readingwriting speed, s
    • 個人化精準腫瘤治療顧問-腦轉移腫瘤

      FutureTech 個人化精準腫瘤治療顧問-腦轉移腫瘤

      PCA-BM includes two models: “Automatic BMs Segmentation AI Model”" Distant Brain Failure Prediction Model". The former one uses C2FNAS (coarse to fine network architecture search) to detect the location, size,number of brain metastases. The latter uses radiomics to extract numerous radiographic featuresemploys machine learning methods such as XGBoost to establish a prognostic model of brain metastases. PCA-BM provides more precision treatment decisions for patientsimproves personalizedaccurate overall stereotactic radiosurgery planning.
    • External Field-Free Spin-Orbit Torque Magnetic Random Access Memory

      AI & IOT Application FutureTech External Field-Free Spin-Orbit Torque Magnetic Random Access Memory

      STT-MRAM: scaling down (submicron scale) along with issues of magnetic propertyintegration with semiconductor processing. SOT-MRAM: fundamental understanding on mechanism, integration with STT-MRAMCMOS for readout. VCMA-MRAM: understand the mechanism behind the observable VCMA phenomenon, integration with other RAMs for write/read.
  • 1